Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinoma
Abstract Purpose Liver cancer, also known as hepatocellular carcinoma (HCC), is one of the most prevalent and lethal malignancies in the world. The management of HCC depends on the underlying hepatic function and histological stage of the neoplasm, potentially encompassing locoregional therapies, su...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-04-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02216-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849737734444285952 |
|---|---|
| author | Yuxuan Li Fengguang Zhai Lili Kong Jie Zhu Hong Li Xiaofeng Jin |
| author_facet | Yuxuan Li Fengguang Zhai Lili Kong Jie Zhu Hong Li Xiaofeng Jin |
| author_sort | Yuxuan Li |
| collection | DOAJ |
| description | Abstract Purpose Liver cancer, also known as hepatocellular carcinoma (HCC), is one of the most prevalent and lethal malignancies in the world. The management of HCC depends on the underlying hepatic function and histological stage of the neoplasm, potentially encompassing locoregional therapies, surgical resection, hepatic transplantation, targeted drug therapies, and immunotherapy. However, the outlook for advanced HCC remains poor, with global 5-year survival rates below 15%. Consequently, it is imperative to identify novel tumor biomarkers for HCC prediction. Methods Multiple public databases were used to analyze PTBP2 expression, potential biological functions, and immune infiltration levels in HCC. In addition, immunohistochemical staining, phenotypic experiments, flow cytometry, and mouse subcutaneous tumors were used to verify the elevated PTBP2 expression and its oncogenic effect in HCC. Results The expression of PTBP2 is abnormally high in liver cancer and promoted the occurrence and development of HCC. Conclusions Our study demonstrated that HCC tissues exhibited increased levels of PTBP2 expression compared to normal liver tissues. Elevated PTBP2 expression has been identified as closely linked to low survival in patients with HCC and could be a clinically independent prognostic factor. Additionally, PTBP2 may influence the development and forecasting of patients with HCC by altering the TME. Moreover, we confirmed the association between PTBP2 expression and HCC, both in vivo and in vitro. |
| format | Article |
| id | doaj-art-dbd8fd086d454227a2c1e8279640c02e |
| institution | DOAJ |
| issn | 2730-6011 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj-art-dbd8fd086d454227a2c1e8279640c02e2025-08-20T03:06:50ZengSpringerDiscover Oncology2730-60112025-04-0116112010.1007/s12672-025-02216-9Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinomaYuxuan Li0Fengguang Zhai1Lili Kong2Jie Zhu3Hong Li4Xiaofeng Jin5Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center of Lihuili Hospital, Ningbo UniversityDepartment of Biochemistry and Molecular Biology, Health Science Center, Ningbo UniversityDepartment of Biochemistry and Molecular Biology, Health Science Center, Ningbo UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center of Lihuili Hospital, Ningbo UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center of Lihuili Hospital, Ningbo UniversityDepartment of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center of Lihuili Hospital, Ningbo UniversityAbstract Purpose Liver cancer, also known as hepatocellular carcinoma (HCC), is one of the most prevalent and lethal malignancies in the world. The management of HCC depends on the underlying hepatic function and histological stage of the neoplasm, potentially encompassing locoregional therapies, surgical resection, hepatic transplantation, targeted drug therapies, and immunotherapy. However, the outlook for advanced HCC remains poor, with global 5-year survival rates below 15%. Consequently, it is imperative to identify novel tumor biomarkers for HCC prediction. Methods Multiple public databases were used to analyze PTBP2 expression, potential biological functions, and immune infiltration levels in HCC. In addition, immunohistochemical staining, phenotypic experiments, flow cytometry, and mouse subcutaneous tumors were used to verify the elevated PTBP2 expression and its oncogenic effect in HCC. Results The expression of PTBP2 is abnormally high in liver cancer and promoted the occurrence and development of HCC. Conclusions Our study demonstrated that HCC tissues exhibited increased levels of PTBP2 expression compared to normal liver tissues. Elevated PTBP2 expression has been identified as closely linked to low survival in patients with HCC and could be a clinically independent prognostic factor. Additionally, PTBP2 may influence the development and forecasting of patients with HCC by altering the TME. Moreover, we confirmed the association between PTBP2 expression and HCC, both in vivo and in vitro.https://doi.org/10.1007/s12672-025-02216-9PTBP2HCCImmune infiltrationProliferationBiomarker |
| spellingShingle | Yuxuan Li Fengguang Zhai Lili Kong Jie Zhu Hong Li Xiaofeng Jin Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinoma Discover Oncology PTBP2 HCC Immune infiltration Proliferation Biomarker |
| title | Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinoma |
| title_full | Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinoma |
| title_fullStr | Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinoma |
| title_full_unstemmed | Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinoma |
| title_short | Analysis and identification of PTBP2 as an oncogene in hepatocellular carcinoma |
| title_sort | analysis and identification of ptbp2 as an oncogene in hepatocellular carcinoma |
| topic | PTBP2 HCC Immune infiltration Proliferation Biomarker |
| url | https://doi.org/10.1007/s12672-025-02216-9 |
| work_keys_str_mv | AT yuxuanli analysisandidentificationofptbp2asanoncogeneinhepatocellularcarcinoma AT fengguangzhai analysisandidentificationofptbp2asanoncogeneinhepatocellularcarcinoma AT lilikong analysisandidentificationofptbp2asanoncogeneinhepatocellularcarcinoma AT jiezhu analysisandidentificationofptbp2asanoncogeneinhepatocellularcarcinoma AT hongli analysisandidentificationofptbp2asanoncogeneinhepatocellularcarcinoma AT xiaofengjin analysisandidentificationofptbp2asanoncogeneinhepatocellularcarcinoma |